Unicycive Therapeutics Inc（UNCY）价格预测UNCYUnicycive Therapeutics Inc

Alphio's UNCY stock price prediction model matches the current Unicycive Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.06 (+0.15%). The 1-week path is $4.99 (-1.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Unicycive Therapeutics is currently not a strong buy due to recent FDA setbacks and price volatility. The stock is priced at $5.265, with an RSI of 39.161 indicating potential oversold conditions. However, the company has faced significant challenges, including a 37% drop in stock price after receiving a Complete Response Letter from the FDA, which highlights ongoing manufacturing issues. The forward P/E ratio is 3.4447, suggesting potential undervaluation, but the risks are substantial given the recent regulatory hurdles and the company's negative net income of $12.823 million in Q1 2026.

Unicycive Therapeutics Inc (UNCY) last closed at $5.05, losing -2.88%. These facts feed the 1-day and 1-week UNCY price prediction above.